Russian Pharmaceutical Forum, 19-21 May 2010, St. Petersburg, Russia

Key Speakers:

Jostein Davidsen General Director Nycomed Russia-CIS

Timofey Nizhegorodtsev Head of the Department for Control over Social Sphere and Trade Federal Antimonopoly Service

Elena Telnova Deputy Head Federal Service for Supervision of Healthcare and Social Devt of RF

Dmitriy Efimov General Director, Nizhpharm and Vice President STADA

Laszlo Sugar CEO Valenta

It is our great pleasure to invite you to attend Adam Smith Conferences' 16th Russian Pharmaceutical Forum, taking place, as always, in Saint-Petersburg, on 19-21 May 2010.
It is our great pleasure to invite you to attend Adam Smith Conferences' 16th Russian Pharmaceutical Forum, taking place, as always, in Saint-Petersburg, on 19-21 May 2010.

Russia's business environment has always been more volatile and unpredictable than in the more well-developed western counties, and with the recent introduction of new price control mechanisms, a promised ban on sales representatives, and intensified Government efforts to encourage further construction of manufacturing facilities within Russia - all market players need to be increasingly flexible and to effectively respond to market changes. Despite the current constraints in the sector, every company is looking for new opportunities that the evolving healthcare system might offer.

As a result , there has never been a better time to organise this Forum. Now, more than ever, it is vital that the industry decision-makers come together to discuss all the burning questions of the day, to compare experiences, share ideas for the future, and of course, to meet all the key people in the market!

It is our great pleasure to invite you to attend Adam Smith Conferences' 16th Russian Pharmaceutical Forum, taking place, as always, in Saint-Petersburg, on 19-21 May 2010.

SPEAKERS CONFIRMED TO DATE INCLUDE:

Arkady Dvorkovich*, Aide to the President of the Russian Federation
Aleksandr Itin, CEO, Valenta Pharmaceuticals
Aleksey Molchanov, General Director, CV Protek
Altan Demirdere, President, Novartis Group Russia and CEO, Sandoz Russia
Andrei Gusev, CEO, Rigla
Andrei Yudanov, Professor of Economics, Finance Academy of the Government of the Russian Federation
David Panikashvili, General Director, Rosta Group
Denis Chetverikov, General Manager, Teva Russia
Dmitriy Efimov, General Director, Nizhpharm and Vice President, STADA
Elena Telnova, Deputy Head, Federal Service for the Supervision of Healthcare and Social Development in the Russian Federation
Irina Chernomorets, Country Division Head, Bayer HealthCare
Jostein Davidsen, General Director, Nycomed Russia - CIS
Svetlana Kosheleva, General Director, Doctor Stoletov
László Pocsaji, General Director of Representation, EGIS Pharmaceuticals Russia
Laszlo Sugar, СEO, Valenta
Michael Crow, Vice President & Area Director CIS, GlaxoSmithKline Pharma
Michel Manon, General Manager, Bristol-Myers Squibb
Milos Petrovic, General Manager, Hoffman la Roche
Patrick Aghanian, General Manager, Sanofi-Aventis Russia
Professor Mondher Toumi, Chair of Market Access, University Claude Bernard Lyon
Timofey Nizhegorodtsev, Head of Department for the Protection of Competition in the Social Sphere and Trade, Federal Antimonopoly Service

SPECIAL FEATURES for the Russian Pharmaceutical Forum 2010:

ANALYTICAL THINK TANK read more...

This think tank will feature trusted experts in the sector, representing the leading market research companies. The panel will analyse the current reform process and its effects on various segments of the industry, and will present a detailed statistical review of the key market segments, therapy areas, products and companies, as well as evaluating key drivers and impediments to future market development.

SPOTLIGHT INTERVIEW read more...

with Denis Chetverikov, General Manager, Teva Russia, offering the chance to hear in-depth insight into the strategic directions at one of the largest pharmaceutical companies in Russia, as well as opinions on the further prospects for market development

CEO PANEL: Achieving Growth in a Volatile Climate read more...

This panel featuring CEO's of the leading pharmaceutical companies working in Russia, will share their thoughts on the future of market development, the needs of the business for the next decade, as well as analysing the most critical elements to any growth strategy.

INTERACTIVE PANEL DISCUSSION ON KEY LEGAL ISSUES IN THE RUSSIAN PHARMACEUTICAL SECTOR read more...

This session will gather together experts from the leading legal companies specialising in pharmaceutical market to debate the practical problems that companies and legal counsels face in their day-to-day business and examine a variety of issues in commercial and contract law that affect company operations and profitability. Topics for discussion include: unfair competition, data protection and data exclusivity, advertising and promotion, pricing and subsidies, and many others

SPECIAL GUEST PRESENTATIONS read more...

At least 4 SPECIAL GUEST PRESENTATIONS by world-renowned strategists and academics, who provide counsel to world leaders, as well as the most powerful companies and investors

SPECIAL FOCUS SESSION on Healthcare and OTC products read more...

featuring a LIVE INTERVIEW with Irina Chernomorets, Country Division Head, Bayer HealthCare, who will share her views on the current problems in the sector and give her evaluation of business prospects in the near future, in an interactive and informative way

REASONS WHY YOU CANNOT AFFORD TO MISS THE PHARMACEUTICAL INDUSTRY EVENT OF 2010:

15 YEARS OF EXPERIENCE IN THE MARKET AND A TOP QUALITY REPUTATION: the Forum is now in its 16th year, and is long established as THE leading annual international gathering for the most senior professionals in the Russian Pharmaceutical Sector - 450 ATTENDEES in 2009 and many more expected in 2010

50 + OUTSTANDING SPEAKER FACULTY, brining together senior executives from the leading and most dynamic local and international producers, distributors, retailers, government officials, business and legal experts

11 MULTI-SPEAKER SESSIONS providing information, which is not available anywhere else on the topics including